Clumax Diagnostic And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 1.67 Cr
as on 15-12-2024
- Paid Up Capital ₹ 1.67 Cr
as on 15-12-2024
- Company Age 20 Year, 25 Days
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 201.90 Cr
as on 15-12-2024
- Satisfied Charges ₹ 318.83 Cr
as on 15-12-2024
- Revenue 25.70%
(FY 2022)
- Profit 81.39%
(FY 2022)
- Ebitda 128.54%
(FY 2022)
- Net Worth -15.15%
(FY 2022)
- Total Assets -8.19%
(FY 2022)
About Clumax Diagnostic And Research Centre
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 1.67 Cr and a paid-up capital of Rs 1.67 Cr.
The company currently has active open charges totaling ₹201.90 Cr. The company has closed loans amounting to ₹318.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Yogeshwaran Nagarajan and Ravi Aggarwal serve as directors at the Company.
- CIN/LLPIN
U85110KA2004PTC035092
- Company No.
035092
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Nov 2004
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Clumax Diagnostic And Research Centre?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Yogeshwaran Nagarajan  | Additional Director | 05-Dec-2022 | Current |
| Ravi Aggarwal | Additional Director | 05-Dec-2022 | Current |
Financial Performance and Corporate Structure Insights of Clumax Diagnostic And Research Centre.
Clumax Diagnostic And Research Centre Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.7% increase. The company also saw a substantial improvement in profitability, with a 81.39% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Clumax Diagnostic And Research Centre?
In 2022, Clumax Diagnostic And Research Centre had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Medall Spark Diagnostics Nashik Private LimitedActive 11 years 7 monthsYogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Scans And Labs Marthahalli Private LimitedActive 13 years 8 months
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Scans And Labs Ranchi Private LimitedActive 9 years 6 months
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
- Medall Visakhapatnam Private LimitedActive 6 years 1 month
Yogeshwaran Nagarajan and Ravi Aggarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 11 Feb 2021 | ₹4.20 Cr | Open |
Others Creation Date: 23 Apr 2019 | ₹92.20 Cr | Open |
Axis Bank Limited Creation Date: 28 Jan 2019 | ₹105.50 Cr | Open |
How Many Employees Work at Clumax Diagnostic And Research Centre?
Unlock and access historical data on people associated with Clumax Diagnostic And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Clumax Diagnostic And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clumax Diagnostic And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
